Excellence | The year in review |
The Year That Was in GI 6 key takeaways from a roller-coaster year
A
s we approach the end of 2021, it’s an apt time to look back at the year. And what a year it was. It’s safe to say that 2021 did not go the way anyone likely expected. David Young, President and Chief Executive Officer of PE GI Solutions, puts himself in this bucket. He recalls feeling optimistic over the summer that the end of pandemic was nearing. This was before the Delta variant hit with full force and slowed down the momentum that was building thanks to the rollout of vaccines and improved COVID-19 testing and treatments. While it’s looking like the year will end with the pandemic still a significant presence in our lives, that doesn’t mean 2021 was a bad year. In fact, for the GI industry, Young sees many positives and remains greatly optimistic about the future of the specialty. But he also recognizes that there is significant work that must be done for GI to emerge from this time with the positive momentum that will help further solidify the specialty’s critical role in our healthcare delivery system. Here are six of Young’s key takeaways for the GI industry from 2021.
1
The industry showed its resilience
While 2020 was undoubtedly one of the most challenging years for healthcare and the GI industry, Young says 2021 wasn’t that far behind. “Consider how we came through the worst of COVID-19, then how we responded from a period of no vaccine to vaccine to the decisions we’ve needed to make concerning vaccinated and unvaccinated staff and patients. We’ve had to figure out how to live with Delta and hotspots. We’re continuing to adjust to the experiences and developments that have changed the way practices and surgery centers have operated, such as telehealth, testing, and masking. Then there are all the things we’ve learned and needed to consider during these periods.” The fact that GI remains strong is quite a testament, Young says. “I’m particularly proud of the way the industry has learned how to deal with COVID-19 and become more sophisticated with decision-making around it. When cases rise, we don’t panic and race to shut down. We apply what we have learned from our experiences and help ensure we can keep moving forward.”
4 PE GI Journal December 2021
2
Efforts around patient engagement have been commendable
During a time when coordinating care has proved difficult at best due to factors including disruption in patient job status, housing, and insurance coverage, Young says the GI industry has still managed to achieve high levels of engagement. “Whether via telehealth, recall programs, or triaging, the ability to get patients to the appropriate care environment has been really impressive,” he says. “The focus on patients has been incredible during this period. That’s not just around delivering care but getting patients to the right place at the right time for the right service and for the right payer. This hasn’t been an easy feat, and yet this is an area where the industry has excelled.”
3
Providers continue to face and respond strongly to pressure
The fact that the GI industry is performing as well as it is speaks volumes when you consider the ongoing challenges facing gastroenterologists and their practices and ASCs, Young says. This includes backlogged patients who still require GI care and services, overworked physicians and staff, a tougher safety and personal protective equipment environment, and the ever-lingering uncertainty that COVID-19 has introduced into day-to-day operations. “Unfortunately, we have the same number of GIs trying to fit in all these patients and prioritize and catch up on the more critical patients,” he says. “You’re working harder than ever, and it’s tiring.” This makes the U.S. Preventive Services Task Force’s recently updated guidelines on colorectal cancer screenings, which dropped the recommended age for screening from 50 to 45, a bit of a mixed bag for the GI industry. While this is certainly a positive for patient care, Young says, and payers are beginning to implement coverage for this younger age, the revised guidelines expand the patient population that should be receiving GI care at a time when gastroenterologists are already struggling to support patients.
